Client
- Name
- ALKERMES
- Description
- Biotechnology company
- Location
- Massachusetts · United States of America
Registrant
- Firm
- CAPITOL DECISIONS, INC.
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Issues regarding access to Pharmacotherapies for addicition: S. 1572/H.R.2596, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2012 S.1599,Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, FY2012 Add to #17 below:National Institute of Drug Abuse (NIDA)
Lobbyistsms CAROL MCDAID · HOLLY MERBAUM STRAIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Natl Drug Control Policy (NDCP) · Health & Human Services, Dept of (HHS) · Substance Abuse & Mental Health Services Administration (SAMHSA)
Alcohol and Drug Abuse
Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 Mental health and addiction parity. Add to #17 below: National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity. Access and reimbursement issues regarding alcohol pharmacotherapies. S.1231, Second Chance Reauthorization Act of 2011, Demonstration project issues.
Lobbyistsms CAROL MCDAID · HOLLY MERBAUM STRAIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Natl Drug Control Policy (NDCP) · Health & Human Services, Dept of (HHS) · Substance Abuse & Mental Health Services Administration (SAMHSA)